Each year, there are approximately 10 million cases of venous thromboembolism (VTE) worldwide. VTE, the formation of blood clots in the vein, is a dangerous and potentially deadly medical condition and is a leading cause ...
Jan 7, 2016
0
15
Shareholders of the drugmaker Perrigo shut the door on a $26-billion hostile takeover bid from Mylan.
Nov 13, 2015
0
3
Shares of Mylan are edging up before the opening bell after the pharmaceutical company went ahead with its hostile, $27.14 billion bid for Perrigo.
Sep 15, 2015
0
4
Horizon Pharma is pushing ahead with its hostile, $2.4-billion bid to buy Depomed by starting an offer to exchange a portion of its stock for shares of the rival drugmaker.
Sep 8, 2015
0
4
Dublin-based pharmaceutical group Shire said Tuesday it had bid $30 billion (27 billion euros) for Baxalta to form a global biotech company, an offer soundly rejected by the US firm.
Aug 4, 2015
0
6
Analysts say they expect more tie-ups are coming in the generic drug industry in the wake of Teva's mammoth deal for the generic drug business of Allergan.
Jul 27, 2015
0
9
Drugmaker Horizon Pharma PLC is boosting its offer for fellow drugmaker Depomed to $33 per share.
Jul 21, 2015
0
4
Over 2001-2011, the national incidence of firearm-related hospitalizations has closely tracked the national stock market performance, suggesting that economic perturbations and resultant insecurities might underlie the perpetuation ...
Apr 16, 2015
0
7
More than a year into Colorado's experiment legalizing marijuana, labs testing the plants are able for the first time to take stock of the drug's potency and contaminants—and openly paint a picture of what's in today's ...
Mar 23, 2015
0
16
In a big year for deal making, the health care industry is a standout. Large drugmakers are buying and selling businesses to control costs and deploy surplus cash. A rising stock market, tax strategies and low interest rates ...
Nov 23, 2014
0
0
